Abstract
AbstractBackgroundChronic pain is a condition with severe impact on many aspects of life, including work, functional ability and quality of life, thereby reducing physical, mental and social well‐being. Despite the high prevalence and burden of chronic pain, it has received disproportionally little attention in research and public policy and the societal costs of chronic pain remain largely unknown. This study aimed to describe the long‐term healthcare and work absence costs of individuals with and without self‐identified chronic pain.MethodsThe study population were participants in two Norwegian population health studies (HUNT3 and Tromsø6). Participants were defined as having chronic pain based on a self‐reported answer to a question on chronic pain in the health studies in 2008. Individuals in the study population were linked to four national register databases on healthcare resource use and work absence.ResultsIn our study, 36% (n = 63,782) self‐reported to have chronic pain and the average years of age was 56.6. The accumulated difference in costs between those with and without chronic pain from 2010 to 2016 was €55,003 (CI: 54,414–55,592) per individual. Extrapolating this to the entire population suggests that chronic pain imposes a yearly burden of 4% of GDP. Eighty per cent of the costs were estimated to be productivity loss.ConclusionInsights from this study can provide a greater understanding of the extent of healthcare use and productivity loss by those with chronic pain and serve as an important basis for improvements in rehabilitation and quality of care, and the education of the public on the burden of chronic pain.SignificanceThis was the first study to estimate the economic burden associated with chronic pain in the general population using linked individual‐level administrative data and self‐reported survey answers. We provide calculations showing that annual costs of chronic pain may be as high as €12 billion or 4% of GDP. Findings from this study highlight the need for a greater understanding of the substantial healthcare use and productivity losses among individuals with chronic pain.
Topics

No keywords indexed for this article. Browse by subject →

References
53
[16]
Persistent Pain and Well-being

Oye Gureje, Michael Von Korff, Gregory E. Simon et al.

JAMA 10.1001/jama.280.2.147
[29]
Legeforeningen. (2020).Normaltariffen. Available from:https://normaltariffen.legeforeningen.no/
[35]
Norges Bank. (2021).Valutakurser. Available from:https://www.norges‐bank.no/tema/Statistikk/Valutakurser/.
[36]
Norwegian Directorate of Health. (2019).Samfunnskostnader ved sykdom og ulykker 2015: Sykdomdsbyrde helsetjenestekostnader og produksjonstap fordelt på sykdomsgrupper.
[37]
Norwegian Medicines Agency. (2020).Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals.
[44]
Sommerschild H. R. (2020)
[46]
Statistics Norway. (2021).National accounts—Table 09189: Gross domestic product in 2016.
[50]
The Research Council of Norway. (2016).Helseforskning finansiert av Norges forskningsråd: Porteføljeanalyse med Health Research Classification System (HRCS).

Showing 50 of 53 references

Cited By
54
Related

You May Also Like